Skip to content
VC FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 8 SOURCES

BONVENTURE

Also known as BonVenture, BonVenture Management GmbH, BONVENTURE 5, BV5

Munich impact VC since 2003 (BonVenture Management GmbH, KAGB-registered); EUR 100m under management; fifth fund BV5 targets EUR 100m for late-seed and Series A.

HEADQUARTERS
München, Germany
FOUNDED
2003
OUTSIDE CAPITAL
Yes
TEAM LISTED
19 people

Focus

STAGES
SeedSeries A
ASSET MIX
Venture capitalImpact
GEOGRAPHY
GermanyEurope

Overview

BONVENTURE is a Munich impact venture capital manager whose first fund (EUR 5m, 2003) it calls the first impact fund closed in Continental Europe. It was initiated in 2002 by Dr. Erwin Stahl with a group of socially committed investors. It invests in four impact areas (digital health, equality and education, climate and nature, sustainable consumption) and reports EUR 100m under management and 60+ investments. Its fifth fund, BONVENTURE 5, targets EUR 100m and leads or co-leads late-seed and Series A rounds with first tickets of EUR 1m to 2.5m.

Investment thesis

'True impact and return': invests in authentic, diverse, impact-driven founders whose impact is scientifically measurable, pre-screening 100% of investments for impact intention and having portfolio impact KPIs audited externally; BV5 plans 15-20 startups with EUR 4-5m each, equally across digital health, equality and education, climate and nature, and sustainable consumption.

PORTFOLIO (20)

  • Bcause
    Education
  • BIOWEG
    Climate & Energy
  • ChargeX
    Mobility & Logistics
  • Fairown
    Consumer & E-commerce
  • Fenecon
    Climate & Energy
  • Gardia
    HealthTech
  • LillianCare
    HealthTech
  • Myo
    HealthTech
  • node.energy
    Climate & Energy
  • OptiMedis
    HealthTech
  • Planeteers
    Climate & Energy
  • R3 Robotics
    Industrial & Manufacturing
  • Resourcify
    Climate & Energy
  • Scrapbees
    Climate & Energy
  • Sira
    Education
  • Specialsitter
    Education
  • The Landbanking Group
    Climate & Energy
  • ViViRA
    HealthTech · since 2024
  • Volunteer Vision
    Education
  • Followfood
    Food & Agriculture

People

  • Dr. Erwin Stahl
    Managing Partner; Geschäftsführender Gesellschafter (initiated the founding in 2002) · source
  • Angela Lawaldt
    Managing Partner; Geschäftsführende Gesellschafterin · source
  • Anna Sophie Blistein
    Partner · source
  • Nikolaj Klebert
    Investment Director · source
  • Benjamin Hollerith
    Investment Associate · source
  • Mariana Pedraza Copete
    Investment Analyst · source
  • Theresa Felder
    Head of Finance · source
  • Christina Smith
    Head of Communications · source
  • Dr. Horst Goss
    Founder and Advisory Partner · source
  • Bernard Jan Wendeln
    Founder and Advisory Partner · source
  • Dr. Axel Seemann
    Advisory Partner · source
  • Philipp Haindl
    Chairman of Investors' Board · source
  • Karenina Schröder
    Member of Investors' Board · source
  • Antonis Schwarz
    Member of Investors' Board · source
  • Jan Tegtmeier
    Member of Investors' Board · source
  • Alexander Wendeln
    Member of Investors' Board · source
  • Michael Silbermann
    Advisor · source
  • Anca Michiu
    Office Manager · source
  • Maximilian Stadler
    Junior Finance Manager · source

Links

Frequently asked questions

BONVENTURE is a VC fund based in München, Germany, founded in 2003.

Yes. BONVENTURE invests its own capital in private companies.

BONVENTURE invests at Seed and Series A stages in HealthTech, Education, Climate & Energy, Consumer & E-commerce, Food & Agriculture and Industrial & Manufacturing.

BONVENTURE's stated ticket size is €1M–€2.5M.

Key people at BONVENTURE include Dr. Erwin Stahl (Managing Partner; Geschäftsführender Gesellschafter (initiated the founding in 2002)), Angela Lawaldt (Managing Partner; Geschäftsführende Gesellschafterin), Anna Sophie Blistein (Partner) and Nikolaj Klebert (Investment Director).

BONVENTURE's investments include Bcause, BIOWEG, ChargeX, Fairown, Fenecon, Gardia, LillianCare and Myo, among others.

The most recent publicly reported investment by BONVENTURE is Vivira Health Lab (ViViRA) (Growth round (follow-on)), announced in May 2026.

BONVENTURE states that it accepts submissions through its official contact page.

Yes. BONVENTURE manages capital from outside investors.